Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 04-Jun-24 4:43 PM View:  | Regenxbio Inc. (RGNX) | 31-May-24 | Grant | 4,790 | -- | -- | 74% 6.5K to 11.29K | |
| 04-Apr-24 4:48 PM View: | Immunovant, Inc. (IMVT) | 02-Apr-24 | Grant | 11,255 | -- | -- | 10% 109.81K to 121.06K | |
| 05-Dec-23 4:25 PM View: | Immunovant, Inc. (IMVT) | 01-Dec-23 | Private Sale | 12,700 | $39.73 | $504,567.00 | (10%) 122.51K to 109.81K | |
| 06-Jun-23 10:00 PM View: | Regenxbio Inc. (RGNX) | 02-Jun-23 | Grant | 3,486 | -- | -- | 116% 3.01K to 6.5K | |
| 14-Apr-23 4:31 PM View: | Immunovant, Inc. (IMVT) | 12-Apr-23 | Grant | 12,523 | -- | -- | 11% 109.98K to 122.51K | |
| 19-Aug-22 4:44 PM View: | Immunovant, Inc. (IMVT) | 17-Aug-22 | Grant | 21,059 | -- | -- | 24% 88.93K to 109.98K | |
| 07-Jun-22 4:21 PM View: | Regenxbio Inc. (RGNX) | 03-Jun-22 | Grant | 3,010 | -- | -- | 100% 0 to 3.01K | |
| 12-Jan-22 5:03 PM View: | Immunovant, Inc. (IMVT) | 10-Jan-22 | Grant | 21,726 | -- | -- | 32% 67.2K to 88.93K | |
| 20-Aug-21 6:14 PM View: | Immunovant, Inc. (IMVT) | 20-Aug-21 | Market Purchase | 7,000 | $7.65 | $53,550.00 | 12% 60.2K to 67.2K | (4%) |
| 23-Mar-21 8:58 AM View: | Immunovant, Inc. (IMVT) | 19-Mar-21 | Grant | 15,500 | -- | -- | 35% 44.7K to 60.2K | |
| 19-Jun-20 4:15 PM View: | Access Pharmaceuticals Inc. (ABEO) | 17-Jun-20 | Grant | 37,954 | -- | -- | 100% 0 to 37.95K | |
| 18-May-20 8:52 AM View: | Immunovant, Inc. (IMVT) | 15-May-20 | Grant | 24,700 | -- | -- | 124% 20.0K to 44.7K | |
| 22-Jan-16 4:09 PM View: | Dyax Corp. (DYAXE.OB) | 22-Jan-16 | Disposition | 751,975 | -- | -- | (98%) 766.98K to 15.0K | |
| 22-Jan-16 4:09 PM View: | Dyax Corp. (DYAXE.OB) | 22-Jan-16 | Disposition | 15,000 | -- | -- | (100%) 15.0K to 0 | |
| 19-Jan-16 4:23 PM View: | Dyax Corp. (DYAXE.OB) | 14-Jan-16 | Option Exercise | 389,011 | $4.77 | $1,856,660.00 | 103% 377.96K to 766.98K | |
| 14-Jan-16 4:15 PM View: | Dyax Corp. (DYAXE.OB) | 12-Jan-16 | Option Exercise | 142,239 | $1.91 | $271,676.00 | 60% 235.72K to 377.96K | |
| 08-Jan-16 4:14 PM View: | Dyax Corp. (DYAXE.OB) | 07-Jan-16 | Option Exercise | 149,375 | $2.66 | $396,783.00 | 173% 86.35K to 235.72K | |
| 19-Aug-15 4:14 PM View: | Dyax Corp. (DYAXE.OB) | 17-Aug-15 | Option Exercise | 116,000 | $6.29 | $729,500.00 | 122% 95.35K to 211.35K | |
| 19-Aug-15 4:14 PM View: | Dyax Corp. (DYAXE.OB) | 17-Aug-15 | Planned Private Option Sale | 116,000 | $22.85 | $2,650,570.00 | (55%) 211.35K to 95.35K | |
| 19-Aug-15 4:14 PM View: | Dyax Corp. (DYAXE.OB) | 17-Aug-15 | Private Sale (Planned) | 9,000 | $22.84 | $205,586.00 | (9%) 95.35K to 86.35K | |
| 06-Mar-15 4:15 PM View: | Dyax Corp. (DYAXE.OB) | 05-Mar-15 | Private Sale (Planned) | 5,000 | $15.86 | $79,282.50 | (5%) 100.35K to 95.35K | |
| 26-Feb-15 4:28 PM View: | Dyax Corp. (DYAXE.OB) | 24-Feb-15 | Private Sale (Planned) | 9,000 | $15.64 | $140,788.00 | (8%) 109.35K to 100.35K | |
| 17-Jun-14 4:10 PM View: | Dyax Corp. (DYAXE.OB) | 13-Jun-14 | Sale | 10,000 | $8.27 | $82,717.00 | (8%) 125.35K to 115.35K | |
| 17-Jun-14 4:10 PM View: | Dyax Corp. (DYAXE.OB) | 13-Jun-14 | Sale | 6,000 | $8.25 | $49,502.40 | (5%) 115.35K to 109.35K | |
| 03-Mar-14 6:55 PM View: | Dyax Corp. (DYAXE.OB) | 27-Feb-14 | Grant | 24,000 | $10.20 | $244,800.00 | (16%) 149.35K to 125.35K | (1%) |
| 26-Feb-14 4:06 PM View: | Dyax Corp. (DYAXE.OB) | 24-Feb-14 | Market Sale (Planned) | 11,875 | $10.37 | $123,195.00 | (10%) 113.22K to 101.35K | |
| 27-Feb-13 4:16 PM View: | Dyax Corp. (DYAXE.OB) | 25-Feb-13 | Market Sale | 4,275 | $3.28 | $14,019.00 | (4%) 117.5K to 113.22K | (134%) |
| 28-Feb-12 5:31 PM View: | Dyax Corp. (DYAXE.OB) | 24-Feb-12 | Grant | 47,500 | -- | -- | 68% 70.0K to 117.5K | |
| 09-Aug-11 4:47 PM View: | Dyax Corp. (DYAXE.OB) | 08-Aug-11 | Market Purchase | 4,000 | $1.34 | $5,360.00 | 7% 60.0K to 64.0K | 471% |
| 09-Aug-11 4:47 PM View: | Dyax Corp. (DYAXE.OB) | 08-Aug-11 | Market Purchase | 6,000 | $1.34 | $8,023.20 | 9% 64.0K to 70.0K | 473% |
| 14-Mar-11 6:17 PM View: | Dyax Corp. (DYAXE.OB) | 11-Mar-11 | Market Purchase | 5,000 | $1.52 | $7,600.00 | 10% 49.0K to 54.0K | 404% |
| 14-Mar-11 6:17 PM View: | Dyax Corp. (DYAXE.OB) | 11-Mar-11 | Market Purchase | 6,000 | $1.52 | $9,116.55 | 11% 54.0K to 60.0K | 404% |
| 25-Aug-10 5:23 PM View: | Dyax Corp. (DYAXE.OB) | 24-Aug-10 | Market Purchase | 3,000 | $2.15 | $6,450.00 | 8% 37.0K to 40.0K | 244% |
| 25-Aug-10 5:23 PM View: | Dyax Corp. (DYAXE.OB) | 24-Aug-10 | Market Purchase | 9,000 | $2.15 | $19,346.40 | 22% 40.0K to 49.0K | 244% |
| 27-May-10 5:09 PM View: | Dyax Corp. (DYAXE.OB) | 27-May-10 | Market Purchase | 6,000 | $2.49 | $14,939.40 | 24% 25.0K to 31.0K | 197% |
| 16-Jun-09 8:48 AM View: | Dyax Corp. (DYAXE.OB) | 15-Jun-09 | Market Purchase | 6,000 | $2.01 | $12,059.50 | 38% 16.0K to 22.0K | 260% |
| 16-Jun-09 8:48 AM View: | Dyax Corp. (DYAXE.OB) | 15-Jun-09 | Market Purchase | 3,000 | $2.01 | $6,029.70 | 14% 22.0K to 25.0K | 260% |
| 01-Dec-08 1:27 PM View: | Dyax Corp. (DYAXE.OB) | 26-Nov-08 | Market Purchase | 16,000 | $2.48 | $39,645.40 | 100% 0 to 16.0K | 171% |
| 28-Jun-07 5:07 PM View: | Bioveris Corp (BIOVE.OB) | 26-Jun-07 | Disposition | 134,025 | $21.50 | $2,881,540.00 | (95%) 140.7K to 6.67K | < 1% |
| 28-Jun-07 5:07 PM View: | Bioveris Corp (BIOVE.OB) | 26-Jun-07 | Disposition | 6,675 | $21.50 | $143,512.00 | (100%) 6.67K to 0 | < 1% |
| 09-Jan-07 4:35 PM View: | Bioveris Corp (BIOVE.OB) | 09-Jan-07 | Grant | 2,000 | -- | -- | 1% 140.34K to 142.34K | |
| 09-Jan-07 4:35 PM View: | Bioveris Corp (BIOVE.OB) | 09-Jan-07 | Gift | 6,000 | -- | -- | (4%) 142.34K to 136.34K | |
| 21-Sep-06 3:06 PM View: | Bioveris Corp (BIOVE.OB) | 20-Sep-06 | Grant | 2,365 | -- | -- | 2% 145.06K to 147.43K | |
| 21-Sep-06 3:06 PM View: | Bioveris Corp (BIOVE.OB) | 20-Sep-06 | Gift | 7,095 | -- | -- | (5%) 147.43K to 140.34K | |
| 19-Feb-04 10:00 PM View: | Bioveris Corp (BIOVE.OB) | 18-Feb-04 | Market Sale | 97,500 | $16.22 | $1,581,000.00 | (40%) 242.56K to 145.06K | (32%) |
| 19-Feb-04 10:00 PM View: | Bioveris Corp (BIOVE.OB) | 17-Feb-04 | Market Sale | 22,500 | $15.93 | $358,400.00 | (13%) 167.56K to 145.06K | (35%) |
| 18-Feb-04 10:00 PM View: | Igen International Inc /de (IGEN) | 13-Feb-04 | Disposition | 114,967 | -- | -- | (100%) 114.97K to 0 | |
| 18-Feb-04 10:00 PM View: | Bioveris Corp (BIOVE.OB) | 13-Feb-04 | Grant | 265,065 | -- | -- | 100% 0 to 265.06K | |
| 10-Feb-04 10:00 PM View: | Igen International Inc /de (IGEN) | 06-Feb-04 | Option Exercise | 42,402 | $10.14 | $429,983.00 | 58% 72.56K to 114.97K |